United States · Health Care · USD (Millions) · Annual
Key financials
USD|Millions
ROE
36.91%
2025 (actual)
ROA
14.37%
2025 (actual)
Gross Margin
74.8%
2025 (actual)
Net Margin
28.08%
2025 (actual)
Total Assets
$136,866.00M
2025 (actual)
Net Income
$18,254.00M
2025 (actual)
Valuation
$255,600.46M
2026 (forecast)
Stock Price
$103.60
Historical & projected performance
USD|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-42.5 pt
Company
Sector average
ROA
-15.7 pt
Company
Gross Margin
-13.4 pt
Company
Sector average
Net Margin
-30.5 pt
Company
Total Assets
+41.8%
Company
Sector average (own scale)
Net Income
-114.1%
Company
Valuation
-43%
Company
Sector average
Stock Price
-43%
Company
Sector average (own scale)
Amounts in USD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Merck & Co., Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.